Clinical trialNCT05786417RecruitingPhase 4Interventional

LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple Chronic Conditions

SponsorYale UniversityEnrollment741AnginaStable Ischemic Heart Disease

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To establish the effectiveness and tolerability of standard of care anti-anginal treatment (beta-blocker and calcium channel blocker medications) in older adults with symptomatic Stable Ischemic Heart Disease (SIHD) and multiple chronic conditions (MCC).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Michael Nanna, MD
Yale University
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Yale School of Medicine
New Haven, Connecticut, United States
Recruiting
Wellstar Research Institute
Marietta, Georgia, United States
Recruiting
Cook County Health
Chicago, Illinois, United States
Recruiting
Brigham and Women'S Hospital
Boston, Massachusetts, United States
Recruiting
Mt. Sinai Health System
New York, New York, United States
Recruiting
Nyc Health and Hospitals, Harlem Hospital
New York, New York, United States
Not, yet, recruiting
Nirvana Integrative Medicine
New York, New York, United States
Recruiting
Duke University, School of Medicine
Durham, North Carolina, United States
Recruiting
Cleveland Clinic
Cleveland, Ohio, United States
Not, yet, recruiting
Inova Health Care Services
Fairfax, Virginia, United States
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Beta blockerCalcium channel blocker

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 10 May 2023
Primary completion: 30 May 2027
Completion: 30 May 2027
Last update posted: 7 Apr 2026
Registered enrollment: 741
Registry id: NCT05786417

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.